nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—ADRB2—autistic disorder	0.974	1	CbGaD
Salmeterol—Arbutamine—ADRB2—autistic disorder	0.00207	0.373	CrCbGaD
Salmeterol—Salbutamol—ADRB2—autistic disorder	0.00201	0.362	CrCbGaD
Salmeterol—Labetalol—ADRB2—autistic disorder	0.00147	0.265	CrCbGaD
Salmeterol—ADRB2—GPCR downstream signaling—GABBR1—autistic disorder	2.8e-05	0.00133	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—SLC25A12—autistic disorder	2.79e-05	0.00133	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—GRM5—autistic disorder	2.78e-05	0.00132	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—VIP—autistic disorder	2.78e-05	0.00132	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—RORA—autistic disorder	2.75e-05	0.00131	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR5A—autistic disorder	2.74e-05	0.0013	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PDE4B—autistic disorder	2.73e-05	0.0013	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—SLC19A1—autistic disorder	2.72e-05	0.00129	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—OXTR—autistic disorder	2.69e-05	0.00128	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—SCT—autistic disorder	2.67e-05	0.00127	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—DHCR7—autistic disorder	2.66e-05	0.00127	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—OPRM1—autistic disorder	2.64e-05	0.00126	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—GABBR1—autistic disorder	2.54e-05	0.00121	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—ADM—autistic disorder	2.54e-05	0.00121	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—EXT1—autistic disorder	2.53e-05	0.0012	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SLC6A8—autistic disorder	2.53e-05	0.0012	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	2.48e-05	0.00118	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PDE4B—autistic disorder	2.48e-05	0.00118	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	2.47e-05	0.00118	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—TDO2—autistic disorder	2.45e-05	0.00117	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—POMC—autistic disorder	2.45e-05	0.00116	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ADSL—autistic disorder	2.42e-05	0.00115	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—DAO—autistic disorder	2.41e-05	0.00115	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—OPRM1—autistic disorder	2.4e-05	0.00114	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—XDH—autistic disorder	2.37e-05	0.00113	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR2A—autistic disorder	2.37e-05	0.00113	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—OXT—autistic disorder	2.35e-05	0.00112	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR1B—autistic disorder	2.35e-05	0.00112	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GABBR2—autistic disorder	2.33e-05	0.00111	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—STX1A—autistic disorder	2.33e-05	0.00111	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—NPAS2—autistic disorder	2.33e-05	0.00111	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—UPB1—autistic disorder	2.31e-05	0.0011	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—DHCR7—autistic disorder	2.31e-05	0.0011	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—TCN2—autistic disorder	2.25e-05	0.00107	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—EXT1—autistic disorder	2.19e-05	0.00104	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SLC6A8—autistic disorder	2.19e-05	0.00104	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	2.18e-05	0.00104	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—DRD1—autistic disorder	2.18e-05	0.00104	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	2.15e-05	0.00102	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ADA—autistic disorder	2.15e-05	0.00102	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ASMT—autistic disorder	2.15e-05	0.00102	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GSTM5—autistic disorder	2.15e-05	0.00102	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR1B—autistic disorder	2.13e-05	0.00101	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—OXT—autistic disorder	2.13e-05	0.00101	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—DRD3—autistic disorder	2.11e-05	0.001	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—DAO—autistic disorder	2.09e-05	0.000992	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR1D—autistic disorder	2.08e-05	0.000988	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—IL5—autistic disorder	2.07e-05	0.000983	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CALCA—autistic disorder	2.04e-05	0.000971	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—COMT—autistic disorder	2.03e-05	0.000966	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—GSTP1—autistic disorder	2.02e-05	0.000961	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SLC25A12—autistic disorder	2.02e-05	0.00096	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—MAOA—autistic disorder	2.02e-05	0.000959	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	2e-05	0.000952	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—UPB1—autistic disorder	2e-05	0.000951	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PRLR—autistic disorder	2e-05	0.000951	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	1.99e-05	0.000948	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—DRD1—autistic disorder	1.98e-05	0.000942	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SLC19A1—autistic disorder	1.96e-05	0.000934	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—RORA—autistic disorder	1.96e-05	0.000931	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GRM8—autistic disorder	1.93e-05	0.000918	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—DRD3—autistic disorder	1.92e-05	0.000912	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—POMC—autistic disorder	1.89e-05	0.000899	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL5—autistic disorder	1.88e-05	0.000893	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—WNT2—autistic disorder	1.87e-05	0.000889	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GSTM5—autistic disorder	1.86e-05	0.000884	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ASMT—autistic disorder	1.86e-05	0.000884	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—GSTM1—autistic disorder	1.86e-05	0.000883	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CALCA—autistic disorder	1.86e-05	0.000882	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GHR—autistic disorder	1.84e-05	0.000876	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MAOB—autistic disorder	1.84e-05	0.000872	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	1.83e-05	0.000871	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PDE4A—autistic disorder	1.82e-05	0.000864	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ADSL—autistic disorder	1.75e-05	0.000832	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SLC25A12—autistic disorder	1.75e-05	0.000831	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ACADSB—autistic disorder	1.74e-05	0.000826	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—INPP1—autistic disorder	1.74e-05	0.000826	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—XDH—autistic disorder	1.72e-05	0.000816	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—TPH2—autistic disorder	1.71e-05	0.000811	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SLC19A1—autistic disorder	1.7e-05	0.000809	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AVPR1A—autistic disorder	1.7e-05	0.000809	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NPAS2—autistic disorder	1.68e-05	0.000801	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—STX1A—autistic disorder	1.68e-05	0.000801	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—DPYD—autistic disorder	1.68e-05	0.000798	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—VIP—autistic disorder	1.64e-05	0.000781	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GRM5—autistic disorder	1.64e-05	0.000781	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—TCN2—autistic disorder	1.63e-05	0.000774	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—AVP—autistic disorder	1.61e-05	0.000765	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—OXTR—autistic disorder	1.59e-05	0.000756	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SCT—autistic disorder	1.57e-05	0.000749	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	1.56e-05	0.000743	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CACNA1C—autistic disorder	1.56e-05	0.000742	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ADA—autistic disorder	1.55e-05	0.000738	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—BTD—autistic disorder	1.55e-05	0.000736	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ADSL—autistic disorder	1.52e-05	0.000721	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GABBR1—autistic disorder	1.5e-05	0.000714	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ADM—autistic disorder	1.5e-05	0.000714	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—XDH—autistic disorder	1.49e-05	0.000707	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—EIF4E—autistic disorder	1.48e-05	0.000702	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PDE4B—autistic disorder	1.46e-05	0.000696	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—AVP—autistic disorder	1.46e-05	0.000694	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NPAS2—autistic disorder	1.46e-05	0.000694	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—STX1A—autistic disorder	1.46e-05	0.000694	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—DHFR—autistic disorder	1.42e-05	0.000675	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—OPRM1—autistic disorder	1.42e-05	0.000674	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—RORA—autistic disorder	1.42e-05	0.000673	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—TCN2—autistic disorder	1.41e-05	0.00067	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PLA2G4A—autistic disorder	1.37e-05	0.000653	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ADA—autistic disorder	1.34e-05	0.000639	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR2A—autistic disorder	1.34e-05	0.000636	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	1.33e-05	0.000632	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MAOB—autistic disorder	1.33e-05	0.000631	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—TDO2—autistic disorder	1.32e-05	0.000626	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—POMC—autistic disorder	1.31e-05	0.000624	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GZMB—autistic disorder	1.3e-05	0.000617	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	1.27e-05	0.000605	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR1B—autistic disorder	1.26e-05	0.000599	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—OXT—autistic disorder	1.26e-05	0.000599	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DHCR7—autistic disorder	1.24e-05	0.000589	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—TPH2—autistic disorder	1.23e-05	0.000586	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—RORA—autistic disorder	1.23e-05	0.000583	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR2A—autistic disorder	1.22e-05	0.000578	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—DPYD—autistic disorder	1.21e-05	0.000577	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC6A8—autistic disorder	1.17e-05	0.000558	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—EXT1—autistic disorder	1.17e-05	0.000558	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PRKCB—autistic disorder	1.17e-05	0.000558	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TSC1—autistic disorder	1.17e-05	0.000556	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—DRD1—autistic disorder	1.17e-05	0.000556	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MAOB—autistic disorder	1.15e-05	0.000546	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NTRK2—autistic disorder	1.14e-05	0.000541	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—DRD3—autistic disorder	1.13e-05	0.000539	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CACNA1C—autistic disorder	1.13e-05	0.000536	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PIK3CG—autistic disorder	1.12e-05	0.000534	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DAO—autistic disorder	1.12e-05	0.000532	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP19A1—autistic disorder	1.11e-05	0.000529	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL5—autistic disorder	1.11e-05	0.000528	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CALCA—autistic disorder	1.1e-05	0.000521	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.09e-05	0.00052	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—UPB1—autistic disorder	1.07e-05	0.00051	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—POMC—autistic disorder	1.07e-05	0.000508	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—TPH2—autistic disorder	1.07e-05	0.000508	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PRKCB—autistic disorder	1.07e-05	0.000507	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—DPYD—autistic disorder	1.05e-05	0.0005	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—COMT—autistic disorder	1.03e-05	0.000491	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GSTP1—autistic disorder	1.03e-05	0.000489	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MAOA—autistic disorder	1.03e-05	0.000488	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—DHFR—autistic disorder	1.03e-05	0.000488	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PIK3CG—autistic disorder	1.02e-05	0.000485	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CAT—autistic disorder	1e-05	0.000476	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTM5—autistic disorder	9.98e-06	0.000475	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ASMT—autistic disorder	9.98e-06	0.000475	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	9.87e-06	0.000469	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CACNA1C—autistic disorder	9.77e-06	0.000464	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—POMC—autistic disorder	9.71e-06	0.000461	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PRL—autistic disorder	9.68e-06	0.00046	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PLA2G4A—autistic disorder	9.45e-06	0.000449	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GSTM1—autistic disorder	9.45e-06	0.000449	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—POMC—autistic disorder	9.39e-06	0.000447	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC25A12—autistic disorder	9.39e-06	0.000446	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC19A1—autistic disorder	9.13e-06	0.000434	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GPX1—autistic disorder	9.05e-06	0.00043	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—DHFR—autistic disorder	8.89e-06	0.000423	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AVP—autistic disorder	8.63e-06	0.00041	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IGF2—autistic disorder	8.59e-06	0.000408	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MTHFR—autistic disorder	8.35e-06	0.000397	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ADSL—autistic disorder	8.14e-06	0.000387	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PLA2G4A—autistic disorder	8.11e-06	0.000386	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP19A1—autistic disorder	8.04e-06	0.000382	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—XDH—autistic disorder	7.98e-06	0.000379	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—IL2—autistic disorder	7.9e-06	0.000376	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MEF2C—autistic disorder	7.89e-06	0.000375	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—STX1A—autistic disorder	7.83e-06	0.000372	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NPAS2—autistic disorder	7.83e-06	0.000372	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOE—autistic disorder	7.78e-06	0.00037	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ITGB3—autistic disorder	7.69e-06	0.000366	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—TCN2—autistic disorder	7.57e-06	0.00036	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	7.49e-06	0.000356	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—COMT—autistic disorder	7.47e-06	0.000355	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GSTP1—autistic disorder	7.44e-06	0.000354	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MAOA—autistic disorder	7.42e-06	0.000353	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CAT—autistic disorder	7.24e-06	0.000344	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ADA—autistic disorder	7.22e-06	0.000343	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR2A—autistic disorder	7.18e-06	0.000341	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL2—autistic disorder	7.18e-06	0.000341	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PIK3CG—autistic disorder	7.02e-06	0.000334	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP19A1—autistic disorder	6.96e-06	0.000331	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PLA2G4A—autistic disorder	6.83e-06	0.000325	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GSTM1—autistic disorder	6.83e-06	0.000325	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TSC2—autistic disorder	6.82e-06	0.000324	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—POMC—autistic disorder	6.68e-06	0.000318	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LEP—autistic disorder	6.68e-06	0.000317	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOE—autistic disorder	6.68e-06	0.000317	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—RORA—autistic disorder	6.58e-06	0.000313	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GPX1—autistic disorder	6.54e-06	0.000311	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	6.53e-06	0.000311	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—COMT—autistic disorder	6.47e-06	0.000308	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GSTP1—autistic disorder	6.44e-06	0.000306	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MAOA—autistic disorder	6.43e-06	0.000305	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PRKCB—autistic disorder	6.3e-06	0.000299	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CAT—autistic disorder	6.27e-06	0.000298	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MAOB—autistic disorder	6.17e-06	0.000293	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MTHFR—autistic disorder	6.04e-06	0.000287	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APC—autistic disorder	6.02e-06	0.000286	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PIK3CG—autistic disorder	6.02e-06	0.000286	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—EGF—autistic disorder	5.96e-06	0.000283	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PLA2G4A—autistic disorder	5.92e-06	0.000281	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GSTM1—autistic disorder	5.92e-06	0.000281	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—POMC—autistic disorder	5.73e-06	0.000273	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—TPH2—autistic disorder	5.73e-06	0.000273	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GPX1—autistic disorder	5.67e-06	0.000269	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DPYD—autistic disorder	5.64e-06	0.000268	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOE—autistic disorder	5.62e-06	0.000267	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IGF1—autistic disorder	5.52e-06	0.000262	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—MAPK1—autistic disorder	5.49e-06	0.000261	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTGS2—autistic disorder	5.33e-06	0.000253	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CACNA1C—autistic disorder	5.24e-06	0.000249	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SERPINE1—autistic disorder	5.24e-06	0.000249	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MTHFR—autistic disorder	5.23e-06	0.000249	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PIK3CG—autistic disorder	5.07e-06	0.000241	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOE—autistic disorder	4.87e-06	0.000232	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—POMC—autistic disorder	4.83e-06	0.00023	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DHFR—autistic disorder	4.77e-06	0.000227	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTEN—autistic disorder	4.65e-06	0.000221	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HRAS—autistic disorder	4.41e-06	0.00021	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PIK3CG—autistic disorder	4.39e-06	0.000209	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL2—autistic disorder	4.24e-06	0.000202	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL6—autistic disorder	4.22e-06	0.000201	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—POMC—autistic disorder	4.18e-06	0.000199	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PTEN—autistic disorder	3.99e-06	0.00019	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTGS2—autistic disorder	3.85e-06	0.000183	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP19A1—autistic disorder	3.74e-06	0.000178	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—COMT—autistic disorder	3.47e-06	0.000165	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTP1—autistic disorder	3.46e-06	0.000164	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MAOA—autistic disorder	3.45e-06	0.000164	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CAT—autistic disorder	3.36e-06	0.00016	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTEN—autistic disorder	3.36e-06	0.00016	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTGS2—autistic disorder	3.34e-06	0.000159	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MAPK1—autistic disorder	3.24e-06	0.000154	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLA2G4A—autistic disorder	3.18e-06	0.000151	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTM1—autistic disorder	3.18e-06	0.000151	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GPX1—autistic disorder	3.04e-06	0.000145	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTEN—autistic disorder	2.91e-06	0.000138	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MTHFR—autistic disorder	2.81e-06	0.000133	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOE—autistic disorder	2.61e-06	0.000124	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HRAS—autistic disorder	2.6e-06	0.000124	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL6—autistic disorder	2.49e-06	0.000118	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PIK3CG—autistic disorder	2.36e-06	0.000112	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—POMC—autistic disorder	2.25e-06	0.000107	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTGS2—autistic disorder	1.79e-06	8.51e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTEN—autistic disorder	1.56e-06	7.43e-05	CbGpPWpGaD
